Ironwood Pharmaceuticals IRWD reported adjusted earnings of 2 cents per share for the fourth quarter of 2024, missing the Zacks Consensus Estimate of 10 cents. The company had recorded break-even ...
Revenue estimates for Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) have increased from $353.37 million to $354.72 million for the full year 2024. However, for 2025, they have declined from $348.42 ...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Zacks Research decreased their Q3 2026 earnings per share (EPS) estimates for shares of Ironwood ...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research reduced their Q2 2025 EPS estimates for Ironwood Pharmaceuticals in a research report issued to clients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback